Metformin intervention prevents cardiac dysfunction in a murine model of adult congenital heart disease

[1]  S. Mirarab,et al.  Sequence Analysis , 2020, Encyclopedia of Bioinformatics and Computational Biology.

[2]  Javier Martín,et al.  Molecular Basis for Dysregulated Activation of NKX2‐5 in the Vascular Remodeling of Systemic Sclerosis , 2018, Arthritis & rheumatology.

[3]  J. Marin,et al.  Genetic Heterogeneity of SLC22 Family of Transporters in Drug Disposition , 2018, Journal of personalized medicine.

[4]  Joseph D. Kay,et al.  Diagnosis and Management of Noncardiac Complications in Adults With Congenital Heart Disease: A Scientific Statement From the American Heart Association. , 2017, Circulation.

[5]  E. Cuyás,et al.  Metformin Potentiates the Benefits of Dietary Restraint: A Metabolomic Study , 2017, International journal of molecular sciences.

[6]  D. Hardie,et al.  The mechanisms of action of metformin , 2017, Diabetologia.

[7]  L. Ford,et al.  Repurposing metformin for the prevention of cancer and cancer recurrence , 2017, Diabetologia.

[8]  S. Griffin,et al.  Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes , 2017, Diabetologia.

[9]  L. Tamariz,et al.  Metformin and ageing: improving ageing outcomes beyond glycaemic control , 2017, Diabetologia.

[10]  M. Young,et al.  Metabolic Origins of Heart Failure , 2017, JACC. Basic to translational science.

[11]  B. Goodpaster,et al.  Metabolic Flexibility in Health and Disease. , 2017, Cell metabolism.

[12]  Fei Yang,et al.  Metformin improves cardiac function in mice with heart failure after myocardial infarction by regulating mitochondrial energy metabolism. , 2017, Biochemical and biophysical research communications.

[13]  Milena B. Furtado,et al.  Point mutations in murine Nkx2-5 phenocopy human congenital heart disease and induce pathogenic Wnt signaling. , 2017, JCI insight.

[14]  R. Tian,et al.  Metabolism in cardiomyopathy: every substrate matters , 2017, Cardiovascular research.

[15]  R. N. Eppinga,et al.  Effect of Metformin on Metabolites and Relation With Myocardial Infarct Size and Left Ventricular Ejection Fraction After Myocardial Infarction , 2017, Circulation. Cardiovascular genetics.

[16]  G. Filippatos,et al.  Mitochondrial function as a therapeutic target in heart failure , 2016, Nature Reviews Cardiology.

[17]  Kai Huang,et al.  Nkx2‐5 Is Expressed in Atherosclerotic Plaques and Attenuates Development of Atherosclerosis in Apolipoprotein E–Deficient Mice , 2016, Journal of the American Heart Association.

[18]  D. Cokkinos,et al.  Metformin protects against infection-induced myocardial dysfunction. , 2016, Metabolism: clinical and experimental.

[19]  Jianguo Xia,et al.  Using MetaboAnalyst 3.0 for Comprehensive Metabolomics Data Analysis , 2016, Current protocols in bioinformatics.

[20]  A. Opotowsky,et al.  Burden of Heart Failure in Adults with Congenital Heart Disease , 2016, Current Heart Failure Reports.

[21]  P. Kaul,et al.  Hospital Readmission of Patients With Congenital Heart Disease in Canada. , 2016, The Canadian journal of cardiology.

[22]  O. Devine,et al.  Congenital Heart Defects in the United StatesClinical Perspective , 2016 .

[23]  H. Klocker,et al.  Oxidative phosphorylation and mitochondrial function differ between human prostate tissue and cultured cells , 2016, The FEBS journal.

[24]  David S Wishart,et al.  Using DrugBank for In Silico Drug Exploration and Discovery , 2016, Current protocols in bioinformatics.

[25]  Rick B. Vega,et al.  The Failing Heart Relies on Ketone Bodies as a Fuel , 2016, Circulation.

[26]  S. John,et al.  Chronic consumption of a western diet induces robust glial activation in aging mice and in a mouse model of Alzheimer’s disease , 2016, Scientific Reports.

[27]  D. Arterburn,et al.  Metabolic Syndrome in Adults With Congenital Heart Disease , 2016, Journal of the American Heart Association.

[28]  M. Cho,et al.  Metformin Prevents Fatty Liver and Improves Balance of White/Brown Adipose in an Obesity Mouse Model by Inducing FGF21 , 2016, Mediators of inflammation.

[29]  A. Ridley,et al.  The Function of Rho-Associated Kinases ROCK1 and ROCK2 in the Pathogenesis of Cardiovascular Disease , 2015, Front. Pharmacol..

[30]  Robert H. Anderson,et al.  Mouse Model of Human Congenital Heart Disease: Progressive Atrioventricular Block Induced by a Heterozygous Nkx2-5 Homeodomain Missense Mutation , 2015, Circulation. Arrhythmia and electrophysiology.

[31]  W. Paulus,et al.  Heart failure with preserved ejection fraction: uncertainties and dilemmas , 2015, European journal of heart failure.

[32]  W. Dietz.  The response of the US Centers for Disease Control and Prevention to the obesity epidemic. , 2015, Annual review of public health.

[33]  B. Kundu,et al.  Remodeling of Glucose Metabolism Precedes Pressure Overload-Induced Left Ventricular Hypertrophy: Review of a Hypothesis , 2015, Cardiology.

[34]  P. Santisteban,et al.  DuOx2 Promoter Regulation by Hormones, Transcriptional Factors and the Coactivator TAZ , 2015, European Thyroid Journal.

[35]  Nandini Dendukuri,et al.  Lifetime Prevalence of Congenital Heart Disease in the General Population From 2000 to 2010 , 2014, Circulation.

[36]  Paul Theodor Pyl,et al.  HTSeq—a Python framework to work with high-throughput sequencing data , 2014, bioRxiv.

[37]  J. Padbury,et al.  Metformin Protects Cardiomyocyte from Doxorubicin Induced Cytotoxicity through an AMP-Activated Protein Kinase Dependent Signaling Pathway: An In Vitro Study , 2014, PloS one.

[38]  J. Tijssen,et al.  Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial. , 2014, JAMA.

[39]  I. Pernicova,et al.  Metformin—mode of action and clinical implications for diabetes and cancer , 2014, Nature Reviews Endocrinology.

[40]  K. Flegal,et al.  Prevalence of childhood and adult obesity in the United States, 2011-2012. , 2014, JAMA.

[41]  G. Smyth,et al.  voom: precision weights unlock linear model analysis tools for RNA-seq read counts , 2014, Genome Biology.

[42]  Joel Stein,et al.  Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. , 2014, Circulation.

[43]  S. Heymans,et al.  Nfat and miR-25 cooperate to reactivate the transcription factor Hand2 in heart failure , 2013, Nature Cell Biology.

[44]  Y. Terauchi,et al.  Metformin prevents liver tumorigenesis induced by high-fat diet in C57Bl/6 mice. , 2013, American journal of physiology. Endocrinology and metabolism.

[45]  Torsten Doenst,et al.  Cardiac Metabolism in Heart Failure: Implications Beyond ATP Production , 2013, Circulation research.

[46]  E. Mercken,et al.  Metformin improves healthspan and lifespan in mice , 2013, Nature Communications.

[47]  C. Silversides,et al.  Hypertension, obesity, and coronary artery disease in the survivors of congenital heart disease. , 2013, The Canadian journal of cardiology.

[48]  Milena B. Furtado,et al.  Functional Characterization of a Novel Mutation in NKX2-5 Associated With Congenital Heart Disease and Adult-Onset Cardiomyopathy , 2013, Circulation. Cardiovascular genetics.

[49]  C. Bezzina,et al.  Genetic variation in T-box binding element functionally affects SCN5A/SCN10A enhancer. , 2012, The Journal of clinical investigation.

[50]  Marcel Martin.  Cutadapt removes adapter sequences from high-throughput sequencing reads , 2011 .

[51]  Mark D. Huffman,et al.  Executive Summary: Heart Disease and Stroke Statistics—2015 Update A Report From the American Heart Association , 2011, Circulation.

[52]  Cory Y. McLean,et al.  GREAT improves functional interpretation of cis-regulatory regions , 2010, Nature Biotechnology.

[53]  Einar Heiberg,et al.  Design and validation of Segment - freely available software for cardiovascular image analysis , 2010, BMC Medical Imaging.

[54]  Ann M. Hess,et al.  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Filtering for increased power for microarray data analysis , 2008 .

[55]  R. Testa,et al.  Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy. , 2007, American journal of physiology. Heart and circulatory physiology.

[56]  J. Molkentin,et al.  Regulation of cardiac hypertrophy by intracellular signalling pathways , 2006, Nature Reviews Molecular Cell Biology.

[57]  H. Senn,et al.  Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics. , 2006, Analytical chemistry.

[58]  V. Stoppioni,et al.  Missense mutation in the transcription factor NKX2-5: a novel molecular event in the pathogenesis of thyroid dysgenesis. , 2006, The Journal of clinical endocrinology and metabolism.

[59]  J. Balschi,et al.  Decreased Contractile and Metabolic Reserve in Peroxisome Proliferator–Activated Receptor-&agr;–Null Hearts Can Be Rescued by Increasing Glucose Transport and Utilization , 2005, Circulation.

[60]  J. Huss,et al.  Mitochondrial energy metabolism in heart failure: a question of balance. , 2005, The Journal of clinical investigation.

[61]  W. Giles,et al.  Nkx2-5 Pathways and Congenital Heart Disease Loss of Ventricular Myocyte Lineage Specification Leads to Progressive Cardiomyopathy and Complete Heart Block , 2004, Cell.

[62]  D. Roden,et al.  Nkx2-5 mutation causes anatomic hypoplasia of the cardiac conduction system. , 2004, The Journal of clinical investigation.

[63]  A. Garnier,et al.  Energy metabolism in heart failure , 2004, The Journal of physiology.

[64]  Toru Kita,et al.  Cardiac p300 Is Involved in Myocyte Growth with Decompensated Heart Failure , 2003, Molecular and Cellular Biology.

[65]  J. Molkentin,et al.  The Transcription Factors GATA4 and dHAND Physically Interact to Synergistically Activate Cardiac Gene Expression through a p300-dependent Mechanism* , 2002, The Journal of Biological Chemistry.

[66]  K. Devriendt,et al.  Progressive AV‐block and anomalous venous return among cardiac anomalies associated with two novel missense mutations in the CSX/NKX2‐5 Gene , 2002, Human mutation.

[67]  J. Saffitz,et al.  A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator- activated receptor alpha- deficient mice. , 1998, The Journal of clinical investigation.

[68]  I. Komuro,et al.  Csx: a murine homeobox-containing gene specifically expressed in the developing heart. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[69]  Thomas J. Wang,et al.  from the American Heart Association , 1990 .

[70]  Charlotte N. Henrichsen,et al.  Explorer A High-Resolution Anatomical Atlas of the Transcriptome in the Mouse Embryo , 2016 .

[71]  C. Folmes,et al.  Myocardial fatty acid metabolism in health and disease. , 2010, Physiological reviews.

[72]  E. Stanley,et al.  Efficient Cre-mediated deletion in cardiac progenitor cells conferred by a 3'UTR-ires-Cre allele of the homeobox gene Nkx2-5. , 2002, The International journal of developmental biology.

[73]  R. Margreiter,et al.  Mitochondria in the Cold , 2000 .

[74]  G. Heldmaier,et al.  Life in the Cold , 2000, Springer Berlin Heidelberg.